Cytochrome P450 Part 3: Impact of Drug‐Drug Interactions

Publisher： John Wiley & Sons Inc

E-ISSN： 2055-2335|39|1|55-58

ISSN： 1445-937x

Source： JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol.39, Iss.1, 2009-03, pp. : 55-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiplatelet Drug Resistance and Drug-Drug Interactions: Role of Cytochrome P450 3A4

By Lau Wei   Gurbel Paul  

Pharmaceutical Research, Vol. 23, Iss. 12, 2006-12 ,pp. : 2691-2708

Springer Publishing Company

Access to resources Recommend Favorite

Heterotropic Cooperativity of Cytochrome P450 3A4 and Potential Drug-Drug Interactions

By  

Current Drug Metabolism, Vol. 2, Iss. 2, 2001-06 ,pp. : 185-198

Bentham Science Publishers

Access to resources Recommend Favorite

Predictions of Metabolic Drug-Drug Interactions Using Physiologically Based Modelling: Two Cytochrome P450 3A4 Substrates Coadministered with Ketoconazole or Verapamil

By Perdaems Nathalie  

Clinical Pharmacokinetics, Vol. 49, Iss. 4, 2010-04 ,pp. : 239-258

Adis International

Access to resources Recommend Favorite

The role of cytochrome P450 in antiretroviral drug interactions

By Walubo Andrew  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 3, Iss. 4, 2007-08 ,pp. : 583-598

Informa Healthcare

Access to resources Recommend Favorite

Cytochrome P450-mediated cardiovascular drug interactions

By Scheen André J  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 9, 2011-09 ,pp. : 1065-1082

Informa Healthcare

Access to resources Recommend Favorite